Charged polylactide co-glycolide microparticles as antigen delivery systems

Bibliography

• O'HAGAN DT: Microparticles as oral vaccines. In: Novel Delivery Systems for Oral Vecchia O'Hagan DT (Ed.) CRC Press, Inc., Boca Raton, FL (1994):175–205.
   Google Scholar
• KOVACSOVICS-BANKOWSKI M, CLARK K, BENACERRAF B, ROCK KL: Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Nati Acad. Sci. USA (1993) 90:4942–4946.
   PubMed Web of Science ®Google Scholar
• OKADA H, TOGUCHI H: Biodegradable microspheres in drug delivery. Crit. Rev Ther. Drug Carrier Syst. (1995) 12:1–99.
   PubMed Web of Science ®Google Scholar
• PUTNEY SD, BURKE PA: Improving protein therapeutics with sustained-release formulations [published erratum appears in Nat. Biotechnol 1998 May;16(5):478]. Nat. Biotechnol (1998) 16:153–157.
   Google Scholar
• ELDRIDGE JH, STAAS JK, MEULBROEK JA, TICE TR, GILLEY RIVI: Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Inman. (1991) 59:2978–2986.
   PubMed Web of Science ®Google Scholar
• O'HAGAN DT, RAHMAN D, MCGEE JP et al.: Biodegradable microparticles as controlled release antigen delivery systems. Immunology (1991) 73:239–242.
   Google Scholar
• SINGH M, SINGH A, TALWAR GP: Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules. Phann. Res. (1991) 8:958–961.
   PubMed Web of Science ®Google Scholar
• O'HAGAN DT, JEFFERY H, ROBERTS MJ, MCGEE JP, DAVIS SS: Controlled release microparticles for vaccine development. Vaccine (1991) 9:768–771.
   PubMed Web of Science ®Google Scholar
• MALOY KJ, DONACHIE AM, O'HAGAN DT, MOWAT AM: Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology (1994) 81:661–667.
   PubMed Web of Science ®Google Scholar
• MOORE A, MCGUIRK P, ADAMS S et al: Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Thl cells. Vaccine (1995) 13: 1741-1749.
   Google Scholar
• NIXON DF, HIOE C, CHEN PD et al:Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine (1996) 14:1523–1530.
   PubMed Web of Science ®Google Scholar
• KANKE M, SNIECINSKI I, DELUCA PP: Interaction of microspheres with blood constituents: I. Uptake of polystyrene spheres by monocytes and granulocytes and effect on immune responsiveness of lymphocytes. J. Parenter. Sci. Technol. (1983) 37:210–217.
   Google Scholar
• TABATA Y, IKADA Y: Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. J. Biota-led. Mater. Res. (1988) 22:837–858.
   PubMed Web of Science ®Google Scholar
• TABATA Y, IKADA Y: Phagocytosis of polymer microspheres by macrophages. Adv. Polymer Sci. (1990) 94:107–141.
   Web of Science ®Google Scholar
• RANDOLPH GJ, INABA K, ROBBIANI DF, STEINMAN RM, MULLER WA: Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity (1999) 11:753–761.
   PubMed Web of Science ®Google Scholar
• LUTSIAK ME, ROBINSON DR, COESTER C, KWON GS, SAMUEL J: Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Phann. Res. (2002) 19:1480–1487.
   PubMed Web of Science ®Google Scholar
• NEWMAN KD, ELAMANCHILI P, KWON GS, SAMUEL J: Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo. I Biota-led. Mater. Res. (2002) 60:480–486.
   PubMed Web of Science ®Google Scholar
• O'HAGAN DT, JEFFERY H, DAVIS SS:Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine (1993) 11:965–969.
   PubMed Web of Science ®Google Scholar
• O'HAGAN DT, UGOZZOLI M, BARACKMAN J et al.: Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1. Vaccine (2000) 18:1793–1801.
   Google Scholar
• OTTEN G, SCHAEFER M, GREER C et al. Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macques by priming with a DNA vaccine and boosting with protein adsorbed polylactide microparticles. Virol. (2003) 77:6087–6092.
   Web of Science ®Google Scholar
• KAZZAZ J, NEIDLEMAN J, SINGH M, OTT G, O'HAGAN DT: Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J. Control. Release (2000) 67:347–356.
   PubMed Web of Science ®Google Scholar
• SINGH M, KAZZAZ J, CHESKO Jet al.: Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidisserotype B. Phann. Sci. (2004) 93:273–282.
   Google Scholar
• JUNG T, KAMM W, BREITENBACH A et al.: Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Phann. Res. (2001) 18:352–360.
   PubMed Web of Science ®Google Scholar
• O'HAGAN DT, JEFFERY H, DAVIS SS:Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine (1993) 11:965–969.
   PubMed Web of Science ®Google Scholar
• SEDER RA, GURUNATHAN S: DNA vaccines-designer vaccines for the 21st century. N Engl. J. Med. (1999) 341:277–278.
   PubMed Web of Science ®Google Scholar
• WANG R, DOOLAN DL, LE TP et al.: Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (1998) 282:476–480.
   PubMed Web of Science ®Google Scholar
• CALAROTA S, BRATT G, NORDLUND S et al.: Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet (1998) 351:1320–1325.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER J, GILBERT SC, BLANCHARD TJ et al.: Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. (1998) 4:397–402.
   PubMed Web of Science ®Google Scholar
• SULLIVAN NJ, SANCHEZ A, ROLLIN PE, YANG ZY, NABEL GJ: Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 408:605–609.
   PubMed Web of Science ®Google Scholar
• AMARA RR, VILLINGER F, ALTMAN JD et al.: Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 292:69–74.
   PubMed Web of Science ®Google Scholar
• HEDLEY ML, CURLEY J, URBAN R: Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. (1998) 4:365–368.
   PubMed Web of Science ®Google Scholar
• WALTER E, MOELLING K, PAVLOVIC J, MERKLE HP: Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. (1999) 61:361–374.
   Google Scholar
• ANDO S, PUTNAM D, PACK DW, LANGER R: PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J. Phann. Sci. (1999) 88:126–130.
   PubMed Web of Science ®Google Scholar
• TINSLEY-BOWN AM, FRETWELL R, DOWSETT AB, DAVIS SL, FARRAR GH: Formulation of poly(DT-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. I Control. Release (2000) 66:229–241.
   PubMed Web of Science ®Google Scholar
• SINGH M, BRIONES M, OTT G, O'HAGAN D: Cationic microparticles: a potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. USA (2000) 97:811–816.
   PubMed Web of Science ®Google Scholar
• BRIONES M, SINGH M, UGOZZOLI M et al.: The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery. Phann. Res. (2001) 18:709–711.
   PubMed Web of Science ®Google Scholar
• O'HAGAN D, SINGH M, UGOZZOLI M et al.: Induction of potent immune responses by cationic microparticles with adsorbed HIV DNA vaccines. 1 Virol. (2001) 75:9037–9043.
   Google Scholar
• DENIS-MIZE KS, DUPUIS M, MACKICHAN ML et al.: Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Titer. (2000) 7:2105–2112.
   Web of Science ®Google Scholar
• OTT G, SINGH M, KAZZAZ Jet al.:A cationic sub-micron emulsion (MF59/ DOTAP) is an effective delivery system for DNA vaccines. J. Control. Release (2002) 79:1–5.
   Google Scholar
• SINGH M, OTT G, KAZZAZ J et al.: Cationic microparticles are an effective delivery system for immune stimulatory CpG DNA. Phann. Res. (2001) 18:1476–1479.
   PubMed Web of Science ®Google Scholar
• TABATA Y, IKADA Y: Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres. Phann. Phannacol. (1987) 39:698–704.
   PubMed Web of Science ®Google Scholar
• PURI N, SINKO PJ: Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. II. In vivo investigation. J. Control. Release (2000) 69:69–80.
   PubMed Web of Science ®Google Scholar
• CLELAND JL, BARRON L, DAUGHERTY A et al.: Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120. Phann. Sci. (1997) 85:1350–1357.
   Google Scholar
• O'HAGAN DT: HIV and mucosal immunity. Lancet (1991) 337:1289.
   Google Scholar
• O'HAGAN DT, SINGH M, KAZZAZ Jet al.: Synergistic adjuvant activity of immunostimulatory DNA and oil/water emulsions for immunization with HIV p55 gag antigen. Vaccine (2002) 20:3389–3398.
   Google Scholar
• LEVINE MM, DOUGAN G: Optimism over vaccines administered via mucosal surfaces. Lancet (1998) 351:1375–1376.
   PubMed Web of Science ®Google Scholar
• O'HAGAN D: Microparticles and polymers for the mucosal delivery of vaccines. Adv. Drug Deify. Rev (1998) 34:305–320.
   Google Scholar
• VAJDY M, O'HAGAN DT: Micropaiticles for intranasal immunization. Adv. Drug Deify. Rev (2001) 51:127–141.
   PubMed Web of Science ®Google Scholar
• SINGH M, VAJDY M, GARDNER J, BRIONES M, O'HAGAN D: Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity. Vaccine (2002) 20:594–602.
   Web of Science ®Google Scholar
• PARK TG, LU W, CROTTS G: Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (D,L-lactic acid-co-glycolic acid) microspheres. Control. Release (1995) 33:211.
   Web of Science ®Google Scholar
• SHENDEROVA A, BURKE TG, SCHWENDEMAN SP: The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pliann. Res. (1999) 16:241–248.
   Google Scholar
• VAN DE WEERT M, HENNINK WE, JISKOOT W: Protein instability in poly(lactic-co-glycolic acid) microparticles. Pliann. Res. (2000) 17:1159–1167.
   Google Scholar
• JOHNSON RE, LANASKI LA, GUPTA V et al.: Stability of atriopeptin III in poly (lactide-co-glycolide) microparticles. Control. Release (1991) 17:61.
   Web of Science ®Google Scholar
• DENIS-MIZE KS, DUPUIS M, SINGH M et al.: Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles. Innnunol. (2003) 225:12–20.
   PubMed Web of Science ®Google Scholar